Does RAMUCIRUMAB Cause Febrile neutropenia? 229 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Febrile neutropenia have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 4.3% of all adverse event reports for RAMUCIRUMAB.
229
Reports of Febrile neutropenia with RAMUCIRUMAB
4.3%
of all RAMUCIRUMAB reports
70
Deaths
148
Hospitalizations
How Dangerous Is Febrile neutropenia From RAMUCIRUMAB?
Of the 229 reports, 70 (30.6%) resulted in death, 148 (64.6%) required hospitalization, and 23 (10.0%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for RAMUCIRUMAB.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
Fatigue (159)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which RAMUCIRUMAB Alternatives Have Lower Febrile neutropenia Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE